Yatsen Holding Ltd (YSG) Stock Analysis and Metrics

Sector: Consumer Defensive Industry: Household & Personal Products CIK: 0001819580

Market Cap 661.77 Mn

P/E -5.74

P/S 1.10

Div. Yield 0.00

ROIC (Qtr) 0.00

Total Debt (Qtr) 3.00 Mn

Revenue Growth (1y) (Qtr) 25.36

Add ratio to table...

About

Yatsen Holding Limited is a leading China based beauty group that develops manufactures and sells color cosmetics and skincare products. Founded in 2016 the company has built a portfolio of brands including Perfect Diary Little Ondine Pink Bear Galénic DR. WU Eve Lom and EANTiM. Its mission is to create an exciting new journey of beauty discovery for consumers worldwide. Yatsen Holding Limited generates revenue primarily from the sale of its color cosmetics and skincare products. The company sells through online channels such as major e commerce...

Yatsen Holding Limited is a leading China based beauty group that develops manufactures and sells color cosmetics and skincare products. Founded in 2016 the company has built a portfolio of brands including Perfect Diary Little Ondine Pink Bear Galénic DR. WU Eve Lom and EANTiM. Its mission is to create an exciting new journey of beauty discovery for consumers worldwide.

Yatsen Holding Limited generates revenue primarily from the sale of its color cosmetics and skincare products. The company sells through online channels such as major e commerce platforms social media platforms and its own official accounts as well as through offline experience stores located in shopping malls across China. Revenue is derived from the retail sales value of products sold under its various brands.

The company operates through the following segments: Color Cosmetics Brands and Skincare Brands.

• The Color Cosmetics Brands segment includes Perfect Diary Little Ondine and Pink Bear and offers a broad range of lip eye and face products targeting mass to mid end consumers. Perfect Diary is the flagship brand providing high quality innovative color cosmetics with designs that appeal to Gen Z and millennials. Little Ondine focuses on trend setting functional makeup such as liquid contour and eyebrow liners while Pink Bear emphasizes high value for money lip gloss products for teenage and young adult customers.

• The Skincare Brands segment comprises Galénic DR. WU mainland China business Eve Lom and EANTiM and offers premium skincare and haircare products. Galénic provides high end dermo cosmetics with scientific formulas derived from plant extracts. DR. WU focuses on dermatologist grade solutions for acne related skin problems using mandelic acid. Eve Lom delivers luxury skincare with natural ingredients that cleanse hydrate tone and exfoliate the skin. EANTiM develops microbiome focused skincare and haircare products aimed at improving skin health.

Yatsen Holding Limited holds a leading position in China's beauty industry with its flagship brand Perfect Diary ranked among the top color cosmetics brands by retail sales value. The company competes with multinational players such as L'Oréal and Estée Lauder as well as domestic brands including Florasphere and Herborist. Competitive advantages stem from its direct to consumer digital marketing strategy a strong network of key opinion leaders frequent intellectual property collaborations robust research and development capabilities and an efficient supply chain supported by a joint venture manufacturing hub.

Yatsen Holding Limited serves primarily Gen Z and millennial consumers located in tier one and tier two cities across China. The company also attracts international customers for its premium skincare brands Galénic and Eve Lom. Its customer base engages through online platforms social media and offline experience stores.

Investment thesis

Bull case

Yatsen’s pivot toward premium skincare has shifted the revenue mix to a higher‑margin segment, evidenced by an 83.2% jump in skincare sales and a 49.2% share of total revenue. This category shift not only improves gross margin, which rose to 78.2%, but also positions the company to benefit from growing consumer willingness to pay for science‑driven products in a mature market. Management’s focus on R&D—spending 4% of revenue on new development and launching multiple hero products such as the VC and AVA serums—signals a robust pipeline that can sustain momentum and drive repeat purchases, thereby boosting customer lifetime value. Coupled with a disciplined marketing spend that has reduced its share of revenue from 73% to 68.3%, the company is effectively translating investment into higher‑margin revenue, creating a sustainable growth engine that outpaces many peers still reliant on volume‑driven tactics.
The company’s digital channel execution has reached a breakthrough, with its flagship makeup brand topping the WeChat video channel and the makeup portfolio exceeding 40% of total sales. Such digital dominance translates into lower distribution costs, real‑time consumer feedback, and scalable growth without the heavy capital outlays required for physical stores. By leveraging data‑driven customer insights (CIM) to refine product assortments, Yatsen can accelerate adoption curves and reduce time‑to‑market for new launches. This technology‑centric approach not only fuels organic sales but also provides a moat against competitors that rely on traditional offline or single‑channel strategies, allowing Yatsen to capture market share from both domestic and foreign brands with limited digital maturity.
Cash and liquidity have strengthened, with cash, restricted cash, and short‑term investments climbing to RMB 1.1 billion and operating cash flow improving due to working‑capital timing around Double Eleven. This buffer permits the company to sustain front‑loaded marketing spend without jeopardizing liquidity, while also providing flexibility to weather short‑term market volatility or to seize opportunistic acquisitions. The disciplined inventory strategy—reflected in reduced fulfillment expense as a percentage of revenue—demonstrates operational efficiency that can translate into higher net margins as scale is achieved. These financial metrics, combined with a projected 15‑30% year‑over‑year revenue growth for FY 2025, suggest that Yatsen is on a path to profitability that investors have under‑priced, especially if it maintains its premium mix and marketing efficiency.
Industry structural shifts toward experience‑centric, science‑backed beauty products favor companies that can innovate quickly and maintain brand prestige. Yatsen’s investment in clinical research, evidenced by multiple papers presented at dermatological conferences, positions it as a thought leader and gives it credibility with discerning consumers. The company’s emphasis on expanding product depth—particularly within its skin‑renewal and anti‑aging categories—means it can capture new segments and cross‑sell within existing loyal customer bases. As the domestic market continues to recover, consumers will seek higher‑value offerings, creating a tailwind for Yatsen’s premium brands that is likely to outpace competitors still anchored in volume‑based growth models.

Yatsen’s pivot toward premium skincare has shifted the revenue mix to a higher‑margin segment, evidenced by an 83.2% jump in skincare sales and a 49.2% share of total revenue. This category shift not only improves gross margin, which rose to 78.2%, but also positions the company to benefit from growing consumer willingness to pay for science‑driven products in a mature market. Management’s focus on R&D—spending 4% of revenue on new development and launching multiple hero products such as the VC and AVA serums—signals a robust pipeline that can sustain momentum and drive repeat purchases, thereby boosting customer lifetime value. Coupled with a disciplined marketing spend that has reduced its share of revenue from 73% to 68.3%, the company is effectively translating investment into higher‑margin revenue, creating a sustainable growth engine that outpaces many peers still reliant on volume‑driven tactics.
The company’s digital channel execution has reached a breakthrough, with its flagship makeup brand topping the WeChat video channel and the makeup portfolio exceeding 40% of total sales. Such digital dominance translates into lower distribution costs, real‑time consumer feedback, and scalable growth without the heavy capital outlays required for physical stores. By leveraging data‑driven customer insights (CIM) to refine product assortments, Yatsen can accelerate adoption curves and reduce time‑to‑market for new launches. This technology‑centric approach not only fuels organic sales but also provides a moat against competitors that rely on traditional offline or single‑channel strategies, allowing Yatsen to capture market share from both domestic and foreign brands with limited digital maturity.
Cash and liquidity have strengthened, with cash, restricted cash, and short‑term investments climbing to RMB 1.1 billion and operating cash flow improving due to working‑capital timing around Double Eleven. This buffer permits the company to sustain front‑loaded marketing spend without jeopardizing liquidity, while also providing flexibility to weather short‑term market volatility or to seize opportunistic acquisitions. The disciplined inventory strategy—reflected in reduced fulfillment expense as a percentage of revenue—demonstrates operational efficiency that can translate into higher net margins as scale is achieved. These financial metrics, combined with a projected 15‑30% year‑over‑year revenue growth for FY 2025, suggest that Yatsen is on a path to profitability that investors have under‑priced, especially if it maintains its premium mix and marketing efficiency.
Industry structural shifts toward experience‑centric, science‑backed beauty products favor companies that can innovate quickly and maintain brand prestige. Yatsen’s investment in clinical research, evidenced by multiple papers presented at dermatological conferences, positions it as a thought leader and gives it credibility with discerning consumers. The company’s emphasis on expanding product depth—particularly within its skin‑renewal and anti‑aging categories—means it can capture new segments and cross‑sell within existing loyal customer bases. As the domestic market continues to recover, consumers will seek higher‑value offerings, creating a tailwind for Yatsen’s premium brands that is likely to outpace competitors still anchored in volume‑based growth models.

Bear case

Despite impressive top‑line growth, Yatsen remains operating at a loss, with a net loss margin of 7% and operating loss margin of 8.4% in FY 2025. These figures illustrate that the company has not yet translated its margin gains into profitability, and the path to profitability is contingent on continued execution of its growth plan—a plan that remains vulnerable to execution risk and market dynamics. If the company fails to maintain its higher‑margin product mix or if marketing efficiencies plateau, the cost structure could revert to a high‑expense regime, eroding any upside from sales growth. The need for sustained investment in R&D and brand building also raises concerns about future capital requirements, especially if the company must scale beyond the current domestic market to remain competitive.
The Double Eleven festival highlighted a significant threat from foreign high‑end brands that are engaging in aggressive, out‑of‑pocket price promotions. CFO Yang acknowledged that such promotions could "load the pantry" for these competitors, potentially eroding Yatsen’s pricing power and margin uplift in future periods. If Yatsen cannot sustain its premium positioning against these price‑driven entrants, it may be forced to engage in a pricing war, which would compress gross margins and dilute brand equity. The company's reliance on e‑commerce channels also exposes it to platform policy shifts and rising marketing costs, which could materially impact profitability if not carefully managed.
Yatsen’s heavy emphasis on hero product launches and brand expansion introduces a concentration risk; success hinges on the continued market acceptance of new products. While several launches have shown strong early sales, the beauty industry is notoriously volatile, and consumer preferences can shift rapidly, leading to underperformance of new SKUs. Should the performance of key hero products falter, the company would face challenges in justifying the higher R&D and marketing spend, potentially stalling future growth initiatives. Moreover, the reliance on a few flagship brands for a large portion of revenue increases vulnerability to brand‑specific disruptions such as regulatory recalls, supply chain disruptions, or negative publicity, which could have outsized impacts on the overall financials.
The company’s forecast of 15‑30% revenue growth for FY 2025, while optimistic, is based on assumptions that may not hold in a competitive and saturated market. Management’s comments suggest that profitability is "on the right track" but remain ambiguous about the timeline and scale of improvement. This lack of clarity could lead to investor disappointment if the company fails to meet market expectations, especially given the high degree of uncertainty surrounding the effectiveness of its new marketing investments and the sustainability of its premium mix. Regulatory changes, evolving consumer behaviors, and potential macroeconomic headwinds such as a slowdown in discretionary spending could further constrain growth prospects and amplify risks that management has not fully articulated.

Despite impressive top‑line growth, Yatsen remains operating at a loss, with a net loss margin of 7% and operating loss margin of 8.4% in FY 2025. These figures illustrate that the company has not yet translated its margin gains into profitability, and the path to profitability is contingent on continued execution of its growth plan—a plan that remains vulnerable to execution risk and market dynamics. If the company fails to maintain its higher‑margin product mix or if marketing efficiencies plateau, the cost structure could revert to a high‑expense regime, eroding any upside from sales growth. The need for sustained investment in R&D and brand building also raises concerns about future capital requirements, especially if the company must scale beyond the current domestic market to remain competitive.
The Double Eleven festival highlighted a significant threat from foreign high‑end brands that are engaging in aggressive, out‑of‑pocket price promotions. CFO Yang acknowledged that such promotions could "load the pantry" for these competitors, potentially eroding Yatsen’s pricing power and margin uplift in future periods. If Yatsen cannot sustain its premium positioning against these price‑driven entrants, it may be forced to engage in a pricing war, which would compress gross margins and dilute brand equity. The company's reliance on e‑commerce channels also exposes it to platform policy shifts and rising marketing costs, which could materially impact profitability if not carefully managed.
Yatsen’s heavy emphasis on hero product launches and brand expansion introduces a concentration risk; success hinges on the continued market acceptance of new products. While several launches have shown strong early sales, the beauty industry is notoriously volatile, and consumer preferences can shift rapidly, leading to underperformance of new SKUs. Should the performance of key hero products falter, the company would face challenges in justifying the higher R&D and marketing spend, potentially stalling future growth initiatives. Moreover, the reliance on a few flagship brands for a large portion of revenue increases vulnerability to brand‑specific disruptions such as regulatory recalls, supply chain disruptions, or negative publicity, which could have outsized impacts on the overall financials.
The company’s forecast of 15‑30% revenue growth for FY 2025, while optimistic, is based on assumptions that may not hold in a competitive and saturated market. Management’s comments suggest that profitability is "on the right track" but remain ambiguous about the timeline and scale of improvement. This lack of clarity could lead to investor disappointment if the company fails to meet market expectations, especially given the high degree of uncertainty surrounding the effectiveness of its new marketing investments and the sustainability of its premium mix. Regulatory changes, evolving consumer behaviors, and potential macroeconomic headwinds such as a slowdown in discretionary spending could further constrain growth prospects and amplify risks that management has not fully articulated.

Peer comparison

Companies in the Household & Personal Products

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	PG	PROCTER & GAMBLE Co	333.15 Bn	20.41	3.84	37.03 Bn
2	UL	Unilever Plc	145.79 Bn	11.72	2.56	32.92 Bn
3	CL	Colgate Palmolive Co	71.25 Bn	34.16	3.43	7.94 Bn
4	KVUE	Kenvue Inc.	32.95 Bn	19.98	2.15	8.66 Bn
5	KMB	Kimberly Clark Corp	32.08 Bn	16.64	1.94	7.08 Bn
6	EL	Estee Lauder Companies Inc	29.30 Bn	-117.06	1.98	6.81 Bn
7	CHD	Church & Dwight Co Inc /De/	22.37 Bn	31.01	400.88	2.40 Bn
8	CLX	Clorox Co /De/	11.05 Bn	14.75	1.63	2.49 Bn

Research Tools

Developers

Yatsen Holding Ltd (NYSE: YSG)

About

Investment thesis

Bull case

Bear case

Peer comparison

Research Tools

Developers

Yatsen Holding Ltd (NYSE: YSG)

About

Investment thesis

Bull case

Bear case

Peer comparison

Create an account

Sign In

Reset Password